Potential of metastin and metastin receptor as biomarkers for urological cancers

doi:10.5410/wjcu.v2.i2.10

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4260)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

293

HTML

1911

Tables (1-1)

196

Sum=2400

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

911

Download

949

Sum=1860

Jul 24, 2013 (publication date) through Jul 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Urology

ISSN

2219-2816

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Clin Urol. Jul 24, 2013; 2(2): 10-14
Published online Jul 24, 2013. doi: 10.5410/wjcu.v2.i2.10

Potential of metastin and metastin receptor as biomarkers for urological cancers

Sunao Shoji, Haruhiro Sato, Tetsuro Tomonaga, Hakushi Kim, Shuichi Soeda, Mayura Nakano, Toyoaki Uchida, Toshiro Terachi, Koichi Takeya

Sunao Shoji, Tetsuro Tomonaga, Hakushi Kim, Toyoaki Uchida, Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo 192-0032, Japan

Haruhiro Sato, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan

Shuichi Soeda, Department of Urology, Tokai University Oiso Hospital, Naka-gun, Kanagawa 259-0198, Japan

Mayura Nakano, Department of Urology, Numazu City Hospital, Numazu, Shizuoka 410-0302, Japan

Toshiro Terachi, Department of Urology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan

Koichi Takeya, Department of Natural Products and Medical Chemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0355, Japan

Author contributions: Shoji S designed research and performed research; Shoji S, Sato H, Tomonaga T, Kim H, Soeda S, Nakano M, Uchida T, Terachi T and Takeya K analyzed data; Shoji S wrote the paper.

Correspondence to: Sunao Shoji, MD, PhD, Department of Urology, Tokai University Hachioji Hospital, 1838 Ishikawa-machi, Hachioji, Tokyo 192-0032, Japan. sunashoj@mail.goo.ne.jp

Telephone: +81-42-6391111 Fax: +81-42-6391111

Received: April 15, 2013
Revised: May 31, 2013
Accepted: June 8, 2013
Published online: July 24, 2013
Processing time: 101 Days and 4.9 Hours

Core Tip

Core tip: Metastin and metastin receptor have attracted interest in the field of cancer because of their novelty and potential to inhibit cancer metastasis. Furthermore, they have potential as suitable molecular biomarkers for urological cancers. However, the results of all of the studies analyzed in this review were retrospectively obtained. Therefore, future studies of metastin and metastin receptor should undergo external validation to ensure consistency across different patient series, since individual institutional studies lack generalization.